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A R T I C L E  I N F O   







A B S T R A C T   
Background/aim: Santander, the capital of Cantabria, Spain (172,000 inhabitants) is 7 km from an industrial 
emission source (IES) of Mn located in a 10,000 inhabitants town (Maliaño) (annual air Mn arithmetic mean =
231.8 ng/m3; reference WHO guideline = 150 ng/m3). Our objective was to compare the motor function of adult 
healthy volunteers living in both places. 
Methods: Cross-sectional study analyzing 130 consecutive participants. Exposure to Mn was assessed in terms of 
source distance from the IES, by Personal Environmental Monitors (PEMs) carried for 24 h by participants 
consisting of a portable impactor connected to a personal pump, and by biomarkers (blood, hair and fingernails). 
The impactor allowed the separation of fine (PM2.5) and coarse (PM10-2.5) particles and for each particle size 
in-vitro bioaccessibility tests with biologically active fluids were performed to separate the soluble (bio-
accessible) from the insoluble (non-bioaccessible) fraction. Mean Differences (MDs) adjusted for age, sex, and 
study level, were obtained for motor function tests results. 
Results: Regarding Grooved Pegboard, overall mean time to complete the test was 59.31 and 65.27 seconds 
(Standard Deviation = 10.11 and 11.69) for dominant and nondominant hands respectively. Statistically sig-
nificant higher times (indicating worse function) were observed when living near the IES in both hands but MDs 
of only 1.22 and 2.05 seconds were obtained after adjusting for the predefined confounders (p = 0.373 and 0.221 
respectively). Regarding Mn levels in their PEMs (in both bioaccessible and non-bioaccessible coarse&fine 
fractions) higher times were computed in participants with higher levels for the bioaccessible-fine fraction, with 
a MD that diminished but still yielded statistical significance after controlling for confounding: adjusted MD =
3.01 more seconds; 95%CI (0.44–5.38), p = 0.022. Poorer results were also observed for fingernails levels. 
Regarding Finger Tapping Test, no statistically significant differences were found with the exception of Mn 
fingernails levels. 
Conclusions: Our results suggest poorer motor function as assessed by Grooved Pegboard test in relation to 
“proximity to IES”, “bioaccessible-fine fraction as determined by PEMs and “Mn fingernails levels”. However, our 
findings were affected by confounding, and only the adjusted MD for the Mn bioaccessible-fine fraction remained 
of sufficient magnitude to maintain statistical significance.   
1. Introduction 
Manganese (Mn) is a trace element, and therefore an essential 
nutrient found in the human body (Chen et al., 2018). However, 
neurological and neuropsychological negative health effects have been 
described in relation to high levels of occupational Mn exposure (Luc-
chini et al., 2009; Williams ATSDR, 2012), mainly in the context of Mn 
ferroalloys plants and welders (Bowler et al., 2006a, b; Lucchini et al., 
1999; Mergler et al., 1994), Mn ore mines (Dlamini et al., 2020), and Mn 
ore processing plants (Roels et al., 1987). 
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Although most health studies on Mn overexposure regard to occu-
pational exposure, a few epidemiological studies have also been pub-
lished in recent decades with regard to environmental airborne 
exposure, as reviewed by Fernández-Olmo et al. (2020), conducted in 
areas near the industrial emission sources (IES) of Mn mentioned above, 
this is, Mn ferroalloys plants (Bowler et al., 2012, 2015, 2016; Kim et al., 
2011; Lucchini et al., 2014; Standridge et al., 2008; Viana et al., 2014), 
Mn ore mines (Guarneros et al., 2013), and Mn ore processing plants 
(Bowler et al., 2012, 2015). Neurological and neuropsychological out-
comes can be classified in these studies into cognitive, motor, olfactory 
and emotional function and mood (Fernández-Olmo et al., 2020). 
In relation to motor function and environmental airborne Mn expo-
sure, a recent meta-analysis by Ruiz-Azcona et al. (2021) identified only 
eight studies (Bowler et al., 2012, 2016; Guarneros et al., 2013; Kim 
et al., 2011; Lucchini et al., 2014; Mergler et al., 1999; Standridge et al., 
2008; Viana et al., 2014). In these studies, the exposed populations were 
located in Southwest Quebec, Canada, where a former Mn alloy pro-
duction plant existed (Mergler et al., 1999); Marietta and East Liverpool, 
Ohio, two towns near a ferromanganese refinery and a Mn ore pro-
cessing plant in the United States (Bowler et al., 2012, 2016; Kim et al., 
2011; Standridge et al., 2008); a Mn mining district living <1 km from a 
manganese processing plant (Tolago/Chiconcoac), in the Molango dis-
trict in the High Sierra of the central Mexican state of Hidalgo (Guar-
neros et al., 2013); Valcamonica, Italy, an industrial region close to 
former Mn alloy plants (Lucchini et al., 2014); Cotegipe, Simões Filho, 
Bahia, Brazil a small community situated at an approximate distance of 
1.5 km from a ferromanganese alloy plant (Viana et al., 2014). Most of 
these areas may be considered as low-density populated. 
In one hand, means of motor function tests scores in these exposed 
populations were compared with populations residing in locations 
farther away from the Mn emission sources in seven studies (Bowler 
et al., 2012; Guarneros et al., 2013; Kim et al., 2011; Lucchini et al., 
2014; Mergler et al., 1999; Standridge et al., 2008; Viana et al., 2014). 
On the other hand, correlation between Mn levels in the exposed pop-
ulations and motor function tests scores was analyzed in three studies 
(Bowler et al., 2016; Standridge et al., 2008; Viana et al., 2014). The 
meta-analysis showed a statistically significant worse motor function in 
exposed, and a negative correlation (the higher the Mn levels, the poorer 
scores). 
Airborne exposure to trace metal(loid)s near IES of such pollutants 
may be assessed by measuring their concentration in particulate matter 
(PM) filters using stationary or personal samplers. Stationary PM sam-
plers have been using for years to determine metals in ambient PM, but 
its spatial representativeness is limited (Fulk et al., 2016). 
PM personal samplers, also known as Personal Environmental 
Monitors (PEM), could solved this limitation but their use is still not 
widely implemented (Graney et al., 2004; Haynes et al., 2012; Lucchini 
et al., 2012; Pollitt et al., 2016; Solís-Vivanco et al., 2009). Finally, 
although PEMs are used in some studies, they only consider the total 
content of metal instead its soluble fraction in a biologically active fluid, 
i.e. its bioaccessibility (Expósito et al., 2021). Different surrogate fluids 
may be used in such bioaccessibility assays, mainly artificial lung fluids 
to assess the inhalation route of exposure (Kastury et al., 2017, 2018; 
Mbengue et al., 2015; Mukhtar and Limbeck, 2013) and gastric fluids to 
assess the oral route (Denys et al., 2012; European Pharmacopoeia, 
2010; USEPA, 2007). It is relevant to differentiate between the bio-
accessible and non-bioaccessible fractions in PM, since the soluble 
(bioaccessible) fraction of PM-bound trace metal(loid)s instead of total 
content may better represent the exposure risk of such pollutants in 
humans (Hernández-Pellón et al., 2018; Weggeberg et al., 2019). Metal 
bioaccessibility in a given fluid mainly depends on the chemical speci-
ation of such metal, which also depends on its source. Thus, metal 
bioaccessibility differs between urban, industrial and rural areas 
(Mukherjee and Agrawal, 2017); for example, Mn inhalation bio-
accessibility near industrial sources was found to be higher than in a 
closer urban area, thus leading to a higher potential risk 
(Hernández-Pellón et al., 2018). With respect to specific studies on the 
relationship between environmental airborne Mn exposure and motor 
function, none of the eight studies included in the meta-analysis have 
evaluated Mn exposure by using PEMs and very few of them quantified 
airborne exposure, indirectly by modelling (Bowler et al., 2012, 2016; 
Kim et al., 2011) or directly by stationary air Mn evaluation (Lucchini 
et al., 2014). 
In addition to personal samplers, the analysis of specific biomarkers 
can also account for the spatial variability of the exposure. A biomarker 
in an epidemiological context, should be able to characterize and 
differentiate exposed and non-exposed groups, as well as to predict 
health disorders, as a result of short- or long-term exposure (Viana et al., 
2014; Zheng et al., 2011). Most of the studies included in the 
meta-analysis on motor function have used biomarkers to determine Mn 
exposure (Bowler et al., 2012; Guarneros et al., 2013; Kim et al., 2011; 
Lucchini et al., 2014; Mergler et al., 1999; Standridge et al., 2008; Viana 
et al., 2014), “whole blood” being the most biological sample used 
(Bowler et al., 2012; Kim et al., 2011; Lucchini et al., 2014; Mergler 
et al., 1999; Standridge et al., 2008) followed by scalp and/or axillary 
hair (Guarneros et al., 2013; Standridge et al., 2008; Viana et al., 2014), 
urine (Lucchini et al., 2014) and fingernails and saliva (Viana et al., 
2014). Since each biomarker has strengths and weaknesses, i.e. blood 
aims to estimate short term exposure, hair aims to estimate an exposure 
of 1–6 months, whereas nails allow to estimate low-level chronic 
exposure (Fernández-Olmo et al., 2020; Ntihabose et al., 2018; Haynes 
et al., 2015; Viana et al., 2014), most of studies use more than one 
biomarker. 
Santander, the capital of Cantabria, Northern Spain with a high 
population density (172,000 inhabitants) is only 7 km from an impor-
tant IES of Mn (a ferromanganese alloy plant) located in a 10,000 in-
habitants town (Maliaño), leading to relatively high levels of airborne 
Mn in comparison with the annual reference guideline given by WHO 
(150 ng/m3). In this context, an annual arithmetic mean of 231.8 ng/m3 
was measured in downtown Maliaño in 2015 (Hernández-Pellón and 
Fernández-Olmo, 2019a); higher monthly values were reported in sites 
located closer to the IES, a cultural center (La Vidriera), mean of 721.9 
ng/m3, and a primary school (Juan de Herrera), mean of 713.9 ng/m3 
(Hernández-Pellón and Fernández-Olmo, 2019b). Even in Santander, an 
arithmetic mean of 60.8 ng/m3 was reported in 2015 (Hernández-Pellón 
and Fernández-Olmo, 2019a), which exceeds the Reference Concentra-
tion (RfC) given by US EPA (50 ng/m3). 
Therefore, the objective of this study was to analyze the impact of 
environmental Mn exposure on motor function in adults living in a re-
gion characterized by high levels of airborne Mn by using PEMs and 
differentiating between bioaccessible and non-bioaccessible fractions 
and between fine and coarse modes, in addition to biomarkers of 
exposure (whole blood, scalp hair and fingernails). 
2. Methods 
2.1. Design, area of study and participants 
A cross-sectional design was used. The study was carried out in 
Santander Bay (Cantabria, northern Spain) where there is a ferroman-
ganese alloy plant that produces more than 100 kt of ferromanganese 
and silicomanganese, annually. The area of study has been described in 
detail elsewhere (Arruti et al., 2010, 2011a, b; Hernández-Pellón and 
Fernández-Olmo, 2019a, b) as well as in the introduction section. 
Participants were recruited from November 2019 to November 2020, 
among a list of 165 potential volunteers obtained by three different 
strategies: a) At the Researchers’ Night organised by the University of 
Cantabria in the 2018 and 2019 sessions in Santander, the project was 
publicised and a list of potential volunteers was obtained. b) An infor-
mation day organised by Camargo Town Council in the La Vidriera 
Cultural Centre (Maliaño), attended by representatives of the different 
Neighbourhood Associations of Maliaño. c) Diffusion by means of 
L. Ruiz-Azcona et al.                                                                                                                                                                                                                           
Neurotoxicology 87 (2021) 195–207
197
informative posters, invitation letters and pamphlets in the Hospital 
Universitario Marqués de Valdecilla (HUMV), Primary Care Centres, 
University of Cantabria and Maliaño Neighbourhood Associations. 
Fig. S1 shows the flow chart to obtain the final study population: 
seventeen out of the 165 preselected candidates could not be contacted 
by phone. Eight people declined to participate when contacting. The 
remaining 140 participants completed a brief questionnaire by phone to 
verify the inclusion criteria of age (between 18–75 years old); and the 
fulfilment of at least one of the following exposure criteria:  
- Residence criterion 1: At least one year of current residence in the 
same place, located up to 10 km away from the IES.  
- Residence criterion 2: ≥ 10 years of residence during the last 15 
years located up to 10 km away from the IES.  
- Workplace criterion (minimum daily working time of 8 h): ≥10 years 
of workplace during the last 15 years located up to 10 km away from 
the main emission source. 
The following exclusion criteria were considered: 
- Neurodegenerative disease diagnosed (cognitive impairment, mul-
tiple sclerosis, Alzheimer’s dementia, Huntington’s chorea and Par-
kinson’s disease) or psychiatric condition (schizophrenia, major 
psychiatric diagnosis, eating disorder and bipolar disorder).  
- Medical sick leave that interferes with cognitive or motor function or 
makes displacement not possible.  
- Current medication prescribed interfering with cognitive or motor 
function (anticonvulsive, antihistamines, neurological or psychiatric 
drugs).  
- History of previous occupational exposure to manganese requiring 
medical treatment.  
- Having worked in Mn related industries.  
- Active alcohol consumption and/or other psychotropic drugs.  
- Lack of understanding of the Spanish language for the purpose of 
completing the tests. 
Finally, among the 140 participants, 130 met the criteria to partici-
pate in the study. This population was divided into two groups: (1) 
highly exposed (n = 65): participants living or working within ≤1.5 km 
from the IES, i.e. those living in Maliaño, where the main Mn source is 
located, and (2) moderately exposed (n = 65): participants living or 
working between >1.5 to ≤10 km from the IES, i.e. those living outside 
Maliaño, mainly in the city of Santander. 
One hundred and twenty-three of the 130 volunteers (94.6 %) met 
the first residence criterion (≥1 last year ≤ 10 km from the Mn source); 
118 (90.8 %) the second (≥10 years in the last 15 years residing ≤10 km 
from the IES) and 128 (98.5 %) the third (≥10 years in the last 15 years 
with workplace ≤10 km from the IES). Table S1 presents the cumulative 
compliance with the residence criteria: 89.2 % of the sample met both 
residency criteria at the same time. 6.9 % met one of them, so 96.2 % of 
the sample met at least 1 of the residency criteria. The remaining n = 5 
(3.8 %) met only the workplace criterion. 
An informed written consent was obtained from each subject. The 
study was approved by the ethical committee of clinical research in 
Cantabria (CEIC) and by the ethical committee of research of the Uni-
versity of Cantabria (CEUC). 
2.2. Data collection. Motor function tests 
Firstly, an individual first appointment was scheduled with each of 
the 130 volunteers at a Testing room of the University of Cantabria that 
met the privacy needs for sensitive evaluations. During each of the ap-
pointments, the sequence of steps was as follows: 
1) Signature of the informed written consent form. 2) Personal 
interview using a structured questionnaire with socio-demographic 
data, place of residence and work and years residing, work history, 
medical history, pharmacological treatments, tobacco and alcohol con-
sumption, psychotropic drugs use and dietary habits including daily 
intake of Mn-rich foods and Mn food supplements. 3) Cognitive and 
motor function tests battery (always in the same order) provided no use 
of alcohol and/or other psychotropic drugs <6 h before testing (no 
active consumption). Tests were similarly measured, administered and 
evaluated among all participants, following standardized instructions by 
a single investigator (L.R.-A), with previous experience in carrying out 
neuropsychological tests in epidemiological studies (Herrero-Montes 
et al., 2019) and trained by neurologist and neuropsychologist of the 
neurology service from the HUMV. 
At the end of the tests, a PEM was handed out and fitted, which the 
subject was required to carry with him/her for at least 24 h. The next 
day, the participant handed over the PEM and then biological samples 
were collected. Specifically, a blood sample, a hair sample from the 
occipital part of the scalp and fingernails were taken. 
The standardized motor function test battery included three tests to 
evaluate motor function. “Eye-hand coordination and motor speed”, 
“self-directed manual speed” and grip strength were measured using the 
Finger Tapping Test (FTT), the Grooved Pegboard (GP) and the Hand 
Dynamometer, respectively (Strauss et al., 2006). 
The Finger Tapping test (Lezak, 2004) is a measure of psychomotor 
speed requiring examinees to tap a lever with their index finger as fast as 
possible in 10 seconds for the dominant (dom) and nondominant 
(nondom) hands separately. The score is the number of taps for each 
hand, recorded by a counter (WPS electronic Tapping Test). 
Self-directed manual speed and tactile manipulative ability was 
assessed with the Grooved Pegboard test (Bornstein, 1986) which re-
quires speeded rotation and insertion of pegs with ridges on them in a 5 
× 5 matrix of holes with the dom and nondom hands. Model 32025 of 
Lafayette Instrument Company was used. The score for each hand is 
based on the time (seconds) required to complete the task. 
Grip strength was assessed in kilograms with the use of the Dyna-
mometer T.K.K. 5401 Grip-D, Takei, Tokyo, Japan (Oteo et al., 2015), 
which participants were asked to squeeze twice for each hand. The 
highest scores from the two measurements with each hand were 
selected. 
2.3. Personal exposure to airborne Mn 
Inhalation personal exposure to size segregated PM was determined 
using a portable impactor (SKC PMI coarse) connected to a personal 
pump (SKC Aircheck XR5000) that operated at a flow rate of 3 lpm. The 
impactor allows the separation of the fine (PM2.5) and coarse (PM10- 
2.5) modes, collecting them on 37 and 25 mm PTFE membrane filters, 
respectively. 
Both filters were analyzed in a two-step procedure according to the 
method developed by Expósito et al. (2021). First, in-vitro bio-
accessibility test was carried out by extracting each filter with 10 mL of 
the selected leaching agent for 24 h (PM2.5) or 1 h (PM10-2.5) in an 
end-over-end rotation incubator system at 30 rpm and 37 ◦C. After the 
leaching test, samples were centrifuged, and the supernatants were 
filtered. According to this procedure, gastric fluid and Artificial Lyso-
somal Fluid (ALF), a common Simulated Lungs Fluid (SLF) used in 
bioaccessibility assays, were selected as surrogate agents to represent 
the body fluids that can be contacted with coarse and fine particles, 
respectively. The rationale behind this choice is that only the fine frac-
tion (PM2.5) reaches the alveoli and comes into contact with lung fluids, 
while the coarse fraction (2.5-10 μm), although deposited first in the 
pharyngeal and tracheal region, is subsequently transported by the 
mucociliary clearance adoral and is mainly swallowed, reaching the 
gastrointestinal tract, coming into contact with the gastric juice (Alpo-
fead et al., 2016; Corona Sánchez et al., 2021; Mukhtar and Limbeck, 
2013). 
Secondly, the non-bioaccessible concentration was obtained after 
digestion of the insoluble fraction according to the European standard 
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method “EN-UNE 14902:2006”, which consisted in an acid digestion of 
the filter in a microwave system (Milestone Ethos One) using closed 
PTFE vessels (HNO3: H2O2, 4:1, up to 220 ◦C). 
Lastly, the concentration of Mn in the leachates obtained from the 
bioaccessibility and total digestion tests was analyzed by inductively 
coupled plasma mass spectrometry (ICP-MS, Agilent 7500 CE), as 
described in Expósito et al. (2021), where limits of detection (LOD) and 
quality control procedures were detailed. The following LODs were 
calculated for the bioaccessible and the non-bioaccessible fractions of 
PM10-2.5, and the bioaccessible and the non-bioaccessible fractions of 
PM2.5, respectively: 0.76, 2.52, 0. 59 and 0.99 ng/m3. The percentage of 
samples below the LOD for the same fractions was 1.5, 40.8, 4.6 and 6.9 
%, respectively. 
2.4. Biomarkers sampling and analysis 
Whole blood samples (7.5 mL) were obtained by venipuncture, 
collected in lithium heparin monovettes developed for metal de-
terminations (Sarstedt, Nümbrecht, Germany). These samples were 
refrigerated for up to a maximum of 14 days until dilution with an 
alkaline solution ((2% (w/v) 1-butanol, 0.05 % (w/v) EDTA, 0.05 % (w/ 
v) triton X-100 and 1% (w/v) NH4OH)) as described in González-Antuña 
et al. (2017) at a minimum blood/alkaline solution ratio of 1/10 (w/w), 
and then analyzed by ICP/MS. 
A washing protocol was developed for scalp hair and fingernails, 
based on that described by Eastman et al. (2013), which is more 
exhaustive than others documented, thus eliminating all exogenous 
metals and ensuring that only endogenous ones are quantified. This 
protocol consists of five stages: a first sonication for 20 min with a 0.5 % 
(w/v) solution of triton X-100, subsequent washing (five times) with 
ultrapure water, a second sonication with a 1 N HNO3 solution, subse-
quent washing with the 1 N HNO3 solution and last washing (five times) 
with ultrapure water, drying in the oven overnight at 65 ◦C. Once 
cleaned, samples are microwave-assisted digested (Milestone, Ethos 
One) at 200 ◦C in a solution of HNO3/H2O2 at a ratio 4 /1 (v/v), and 
finally analyzed by ICP/MS. Details on the ICP-MS measurements of Mn 
concentration in all these matrices can be found in Markiv et al. (2020). 
All reagents used for the treatment and preparation of the samples 
were of analytical grade provided by Merck and PanReac AppliChem 
(Darmstadt, Germany). Details on the ICP-MS measurements of Mn 
concentration and LODs determination in all these matrices can be 
found in Markiv et al. (2020). The following LODs were calculated: 0.74 
μg/L for whole blood, 3.37–115.86 ng/g for scalp hair and 9.76–89.23 
ng/g for fingernails. All Mn concentrations in these matrices were above 
the LOD. 
2.5. Statistical analysis 
A value of LOD/2 was assigned for Mn concentrations below the 
LOD. Categorical and discrete variables were expressed as counts (per-
centage). Continuous variables were expressed as mean and Standard 
Deviation (SD) and/or median and interquartile ranges (IQR). Statistical 
differences between groups were assessed with the Chi-square test using 
Yates’ correction or Fisher’s exact test, when appropriate, for categorical 
variables. Continuous variables were compared with the Student’s T test 
(for equal or different variances, depending on the previous result in the 
Levene test) in relation to comparison of Means and U Mann Whitney 
Test in relation to comparison of Medians. The correlation between 
exposure and Motor test scores as continuous variables was calculated 
using the Spearman’s rank correlation coefficient (rho). 
Crude and adjusted Mean Differences (MDs) were obtained by using 
a linear regression model. To estimate the strength of associations, the 
exposure indices, biomarkers and motor tests scores were divided into 
dichotomous variables (low versus high values) according to the median 
and adjusted odds ratios (OR) with their 95 % confidence intervals (CI); 
95 % CIs were calculated using unconditional logistic regression. The 
following confounders were established for inclusion in the models: age 
(as a continuous variable), sex, educational level (ordinal categorized), 
and number of years of residence (continuous). Three multivariable 
models were performed: the first one with age and sex, the second one 
adding educational level, and the last one with all covariates and also 
including years of residence. In addition, diet, alcohol consumption, 
smoking, and employment status were considered as potential con-
founders but did not influence model results. 
The level of statistical significance was set at 0.05 and all tests were 
two-tailed. Data were analyzed using SPSS statistical software package 
24.0 (SPSS, Inc., Chicago, IL, USA). 
3. Results 
3.1. Mn levels and basal characteristics of Study population 
Table 1 shows the Mn levels of participants in PEMs and biomarkers 
as a function of proximity to IES. High SDs were observed in all of the 
studied fractions. Despite this variability, all Mn determinations in PEMs 
(in both bioaccessible and non-bioaccessible coarse&fine and total 
fractions) were statistically significantly higher in participants residing 
at a shorter distance (≤ 1.5 km) from the IES compared to those residing 
at greater distance (> 1.5 km and ≤10 km) considered as highly and 
moderately exposed respectively, and presenting a negative correlation 
(the shorter distance, the higher levels) (see Table S2). Regarding bio-
markers, only determinations from fingernails were significantly higher 
among participants residing at a shorter distance (≤ 1.5 km). No Mean 
differences were found in blood Mn levels. In relation to scalp hair Mn 
levels, higher values were observed for residents living at a shorter 
distance from the IES, but only the median comparison reached statis-
tical significance (see Table 1). Regarding correlations, a positive non- 
statistically significant correlation was obtained between blood Mn 
levels and source distance from the IES and a negative nonsignificant 
correlation was obtained for scalp hair Mn levels (see Table S2). 
The overall mean age of the study participants was 41.72 years [SD 
13.97], with an statistically significant association between an older age 
and worse motor function as assessed by GP for both dom and nondom 
hands (see Table 2), of borderline significance for FTT (p = 0.055 and 
0.049) for dom and nondom hands respectively (See Table S3) and also 
statistically significant (p = 0.016) for nondom hand in relation to 
Dynamometer assessment (See Table S4). 
Ninety five out of 130 participants (73.1 %) were female. Sex (being 
man) was associated with statistically significant higher time to com-
plete GP for the nondom hand (see Table 2) and being woman with 
lower number of taps (See Table S3) in both hands. As expected, being 
female was associated with statistically significant worse results for both 
dom and nondom hands in Dynamometer (p < 0.001). No male scored 
below 27.70 and 24.70 kg (overall median cut-off points for the dom and 
nondom hands) (See Table S4). 
Regarding educational level: 55.4 % had university studies (14.6 % 
Bachelor’s Degree and 40.8 % University Degree), 23.1 % high school 
education, 16.9 % secondary school education and 4.6 % primary edu-
cation. The lower the level of education, the longer the times to com-
plete the GP test (p = 0.006 and p < 0.001 for dom and nondom hands 
respectively) (see Table 2). Regarding FTT, no statistically significant 
differences were observed for educational level (p = 0.161 and p <
0.192 for dom and nondom hands respectively), although lower 
educational levels were more prevalent in those with lower number of 
taps (See Table S3). No significant differences were observed for the 
Dynamometer either (See Table S4). 
The longer the number of years of residence, the worse the motor 
function test results with statistically significant huge differences in the 
GP and FTT and of smaller magnitude but also significant for the 
Dynamometer (see Tables 2 and S3 and S4). 
In terms of employment status, some categories were associated with 
better or worse scores for the GP and FTT (see Tables 2 S3). After 
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adjusting for age, these associations disappeared (data not shown in 
tables). For the rest of the baseline characteristics analyzed, no statis-
tically significant differences were observed. 
3.2. Motor function results 
Regarding GP, overall mean time to complete the test was 59.31 and 
65.27 s (SD = 10.11 and 11.69) for dom and nondom hands, with me-
dians of 57.77 and 61.47 respectively (see Table S5). 
Table 1 
Mn levels in PM personal samplers (PEMs) and biomarkers as a function of proximity to Industrial Emission Source (IES).   
Source distance from IES  
Greater distance (>1.5 km) (n = 65) Shorter distance (≤ 1.5 km) (n = 65) Total (n = 130) p value 
PEMs (ng/m3)        
Coarse fraction (PM10-2.5)        
Bioaccessible        
Arithmetic Mean, SD 14.61 38.46 107.62 242.15 61.11 178.90 0.003* 
Geometric Mean 6.04  40.34  15.61   
Median, P95 5.62 53.99 45.91 288.27 13.61 249.11 <0.001** 
Range: min, max 0.38 300.66 2.06 1837.38 0.38 1837.38  
Interquartile Range (P25, P75) 3.26 12.75 14.61 116.42 4.5 52.19  
Non-Bioaccessible        
Arithmetic Mean, SD 4.02 7.23 19.62 51.31 11.82 37.33 0.018 
Geometric Mean 2.27  7.36  4.09   
Median, P95 1.26 24.24 8.19 74.55 3.39 39.73 <0.001 
Range: min, max 1.26 39.12 1.26 402.47 1.26 402.47  
Interquartile Range (P25, P75) 1.26 4.06 2.65 19.08 1.26 9.2  
Total (Bio + Non-Bio)        
Arithmetic Mean, SD 18.63 43.92 127.24 292.37 72.93 215.26 0.004 
Geometric Mean 9.1  50.34  21.41   
Median, P95 7.86 73.44 53.49 344.12 16.47 289.20 <0.001 
Range: min, max 1.64 339.79 3.32 2239.86 1.64 2239.86  
Interquartile Range (P25, P75) 4.78 15.02 18.43 128.18 6.79 60.83  
Fine fraction (PM2.5)        
Bioaccessible        
Arithmetic Mean, SD 23.42 40.46 109.2 178.3 66.31 135.79 <0.001 
Geometric Mean 7.46  36.81  16.57   
Median, P95 8.07 86.23 34.23 472.05 17.05 315.47 <0.001 
Range: min, max 0.3 245.01 1.11 899.2 0.3 899.2  
Interquartile Range (P25, P75) 2.29 29.97 11.14 148.83 4.89 55.29  
Non-Bioaccessible        
Arithmetic Mean, SD 8.32 17.27 16.96 22.85 12.64 20.64 0.017 
Geometric Mean 4.05  8.29  5.8   
Median, P95 4.33 40.27 7.5 67.17 5.8 61.23 <0.001 
Range: min, max 0.5 125.29 0.5 103.33 0.5 125.29  
Interquartile Range (P25, P75) 2.17 7.89 3.74 16.66 2.84 10.22  
Total (Bio + Non-Bio)        
Arithmetic Mean, SD 31.74 48.43 126.16 190.1 78.95 146.08 <0.001 
Geometric Mean 13.96  50  26.42   
Median, P95 12.78 157.01 44.58 503.66 25 350.58 <0.001 
Range: min, max 0.79 252.77 3.99 937.87 0.79 937.87  
Interquartile Range (P25, P75) 5.63 38.53 16.08 157.85 9.48 78.36  
All fractions (PM10)        
Total (Bio + Non-Bio)        
Arithmetic Mean, SD 50.38 81.23 253.4 440.67 151.89 331.66 0.001 
Geometric Mean 25.4  111.33  53.18   
Median, P95 19.55 235.26 105.67 985.84 43.87 577.23 <0.001 
Range: min, max 4.23 520.43 7.36 3145.27 4.23 3145.27  
Interquartile Range (P25, P75) 10.85 56.22 39.63 318.36 17.41 165.88  
Biomarkers        
Blood Mn (μg/L)        
Arithmetic Mean, SD 9.86 3.11 10.04 3.65 9.95 3.38 0.759 
Geometric Mean 9.34  9.49  9.42   
Median, P95 9.68 16.63 9.16 16.13 9.58 16.01 0.865 
Range: min, max 2.12 18.33 4.6 26.76 2.12 26.76  
Interquartile Range (P25, P75) 7.82 11.88 7.41 11.79 7.65 11.87  
Scalp hair Mn (ng/g)        
Arithmetic Mean, SD 229.88 320.02 529.64 1975.6 380.98 1422.85 0.244 
Geometric Mean 150.06  231.76  186.82   
Median, P95 132.68 646.37 235.45 786.2 185.3 748.01 0.005 
Range: min, max 13.22 2380.07 30.61 15730.27 13.22 15730.27  
Interquartile Range (P25, P75) 75.83 293.24 149.53 333.49 115.95 300.6  
Fingernails Mn (ng/g)        
Arithmetic Mean, SD 433.37 308.8 1440.05 1386.42 936.71 1120.51 <0.001 
Geometric Mean 325.79  1012.3  574.28   
Median, P95 331.28 1054.05 917.87 5243.84 555.27 3549.18 <0.001 
Range: min, max 29.29 1202.67 172.36 6437.22 29.29 6437.22  
Interquartile Range (P25, P75) 189.34 636.99 543.49 1672.19 301.7 1048.96  
SD = Standard Deviation. P25 = 25th percentile. P75 = 75th percentile. P95 = 95th percentile. * Student’s T p values. ** Mann Whitney U p values. 
L. Ruiz-Azcona et al.                                                                                                                                                                                                                           
Neurotoxicology 87 (2021) 195–207
200
Crude statistically significant higher times (indicating worse func-
tion) were observed when living near the IES in both hands (p = 0.024 
and 0.014 respectively) (see Tables 3 and S6) with a crude MD of 3.98; 
95%CI (0.52–7.43) and 5.02; 95%CI (1.04–9.00) more seconds for dom 
and nondom hands (see Table 3) with supporting statistically significant 
correlations of -0.178 and -0.258 respectively (see Table S7). After 
adjusting for age and sex, these MDs diminished, being of only 2.31 and 
3.22 s respectively, and losing statistical significance. When educational 
level was added in the multivariate model, adjusted MDs of 1.22 and 
2.05 s were obtained (p = 0.373 and 0.221 respectively) (see Table 3). 
Table S8 shows associations between source distance and GP results 
dichotomous categorized in higher and lower values according to me-
dian. Living near the IES was associated with a 2.92-fold increase of 
having GP times higher than 61.47 s for the nondom hand: Crude OR =
2.92; 95%CI (1.43–5.95), p = 0.003. Statistical significance remained 
after adjusting for age, sex and educational level: adjusted OR = 2.51; 
95%CI (1.07–5.90), p = 0.035 (see Tables S8 and S9). 
For GP and Mn levels in PEMs (in both bioaccessible and non- 
bioaccessible coarse&fine fractions) higher times were computed in 
participants with higher levels in the bivariate analysis but yielding 
statistical significance only for the bioaccessible-fine fraction with a 
crude MD of 3.56 more seconds; 95%CI (0.09–7.03), p = 0.044 (see 
Tables 3 and S6). This difference diminished but still yielded statistical 
significance after controlling for confounding (age, sex and educational 
level): adjusted MD = 3.01 more seconds; 95%CI (0.44–5.58), p = 0.022 
(see Table 3). Positive crude and adjusted OR were obtained (indicated a 
higher risk of worse function) but without yielding statistical 
significance (see Tables S8 and S9). 
In relation to biomarkers, statistically significant higher times in GP 
were observed in participants with higher Mn fingernails levels with a 
crude MD of 6.04; 95%CI (2.45–9.63) and 7.24; 95%CI (3.04–11.44) 
more seconds respectively for dom and nondom hands (p = 0.001) (see 
Tables 3 and S6) and supported by significant correlations of 0.237 and 
0.275 respectively (See Table S7). After adjusting for age, sex and 
educational level, these associations diminished and lost statistical sig-
nificance: adjusted MD for the dom hand = 1.93 more seconds; 95%CI 
(-0.96 to 4.82), p = 0.189 and adjusted MD for the nondom hand = 2.84 
more seconds; 95%CI (-0.76 to 6.44), p = 0.121 (see Table 3). In the 
form of ORs, the crude associations for higher Mn fingernails levels 
[crude OR dom hand = 2.50; 95%CI (1.18–5.28), p = 0.017 and crude 
OR nondom hand = 3.11; 95%CI (1.46–6.63), p = 0.003], diminished 
and lost also statistical significance after adjusting for the covariates 
mentioned above: ORa2 dom hand = 1.36; 95%CI (0.53–3.49), p =
0.519 and ORa2 nondom hand = 2.17; 95%CI (0.89–5.29), p = 0.088 
(see Tables S8 and S9). 
Regarding FTT, the mean number of taps per 10 s was 68.27 and 
60.25 s (SD = 11.32 and 11.72), with medians of 68.00 and 61.50 taps 
for the dom and nondom hands respectively (see Table S5). 
No statistically significant crude or adjusted mean differences were 
found for exposure indices (see Table 4) but in the form of OR, statis-
tically significant crude and adjusted OR were obtained in the nondom 
hand for the bioaccessible-fine fraction: ORa2 nondom hand = 2.17; 
95%CI (1.03–4.57), p = 0.041 and the Total fine fraction (Bio + Non- 
Bio): ORa2 nondom hand = 2.15; 95%CI (1.01–4.57), p = 0.047 (see 
Table 2 
Characteristics of study population as a function of Grooved Pegboard (GP) results*.  
Characteristics GP (dominant hand) GP (nondominant hand)  
Higher times 
>57.81 s (n =
65) 
Lower times 
≤57.80 s (n =
65) 
Total (n = 130) p value Higher times 
>61.48 s (n =
65) 
Lower times 
≤61.47 s (n =
65) 
Total (n = 130) p value 
Age (Mean, SD) 49.89 13.48 33.54 8.7 41.72 13.97 <0.001 48.28 14.79 35.15 9.34 41.72 13.97 <0.001 
(range: min, max) 21.00 71 20 52 20 71  20 71 21 61 20 71  
Sex (n, %)       0.075       0.010 
Female 43.00 66.2% 52 80.0% 95 73.1%  41 63.1% 54 83.1% 95 73.1%  
Male 22.00 33.8% 13 20.0% 35 26.9%  24 36.9% 11 16.9% 35 26.9%  
Educational level (n, %)       0.006       <0.001 
Primary education 6.00 9.2% 0 0.0% 6 4.6%  6 9.2% 0 0.0% 6 4.6%  
Secondary Education/ Vocational 
education and Training 
15.00 23.1% 7 10.8% 22 16.9%  15 23.1% 7 10.8% 22 16.9%  
High school level/ Certificate of 
Higher Education 
16.00 24.6% 14 21.5% 30 23.1%  20 30.8% 10 15.4% 30 23.1%  
University studies (Bachelor’s 
Degree) 
10.00 15.4% 9 13.8% 19 14.6%  6 9.2% 13 20.0% 19 14.6%  
University studies (University 
Degree) 
18.00 27.7% 35 53.8% 53 40.8%  18 27.7% 35 53.8% 53 40.8%  
Years residing (Mean, SD) 19.69 14.91 10.77 10.63 15.23 13.65 <0.001 20.25 15.15 10.22 9.75 15.23 13.65 <0.001 
(range: min, max) 1.00 71 1 45 1 71  1 71 1 40 1 71  
Employment status       0.003       0.003 
Employed full-time 43.00 66.2% 54 83.1% 97 74.6%  40 61.5% 57 87.7% 97 74.6%  
Unemployed 3.00 4.6% 2 3.1% 5 3.8%  2 3.1% 3 4.6% 5 3.8%  
Housewife 3.00 4.6% 2 3.1% 5 3.8%  4 6.2% 1 1.5% 5 3.8%  
Retired 13.00 20.0% 0 0.0% 13 10.0%  12 18.5% 1 1.5% 13 10.0%  
Full-time student 3.00 4.6% 7 10.8% 10 7.7%  7 10.8% 3 4.6% 10 7.7%  
Smoking Status       0.369       0.516 
Non-smoker 40.00 61.5% 44 67.7% 84 64.6%  39 60.0% 45 69.2% 84 64.6%  
Former 14.00 21.5% 8 12.3% 22 16.9%  13 20.0% 9 13.8% 22 16.9%  
Current 11.00 16.9% 13 20.0% 24 18.5%  13 20.0% 11 16.9% 24 18.5%  
Alcohol Status       0.597       0.113 
Never 34.00 52.3% 37 56.9% 71 54.6%  31 47.7% 40 61.5% 71 54.6%  
Ever 31.00 47.7% 28 43.1% 59 45.4%  34 52.3% 25 38.5% 59 45.4%  
Average of pure ethanol (g/week)       0.104       0.384 
0 34.00 52.3% 37 56.9% 71 54.6%  31 47.7% 40 61.5% 71 54.6%  
1− 24 16.00 24.6% 6 9.2% 22 16.9%  14 21.5% 8 12.3% 22 16.9%  
25− 74 13.00 20.0% 20 30.8% 33 25.4%  18 27.7% 15 23.1% 33 25.4%  
>75 2.00 3.1% 2 3.1% 4 3.1%  2 3.1% 2 3.1% 4 3.1%  
SD = Standard Deviation. 
* Higher times to complete the test indicate worse motor function. 
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Table 3 
Mean Differences for Grooved Pegboard test (dominant and nondominant hand) according to Mn exposure indices and biomarkers.   
Grooved Pegboard (seconds)*  
MD 
crude 
95 % CI p 
value 
MDa1 95 % CI p 
value 
MDa2 95 % CI p 
value 
MDa3 95 % CI p 
value 
Exposure 
indices                 
Source 
distance from 
IES (≤ 1.5 vs 
1.5þ km)                 
dom hand 3.98 0.52 7.43 0.024 2.31 − 0.39 5.02 0.093 1.22 − 1.48 3.92 0.373 0.82 − 1.92 3.56 0.554 
nondom hand 5.02 1.04 9 0.014 3.22 − 0.05 6.5 0.054 2.05 − 1.25 5.35 0.221 1.24 − 2.05 4.53 0.458 
PM personal 
samplers (ng/ 
m3)                 
Coarse fraction 
(PM10-2.5)                 
Bioaccessible 
(13.62+ vs 
≤13.61 ng/m3)                 
dom hand 1.07 − 2.44 4.59 0.547 0.55 − 2.16 3.25 0.691 − 0.62 − 3.30 2.06 0.647 − 1.05 − 3.74 1.65 0.443 
nondom hand 1.67 − 2.4 5.73 0.418 1.08 − 2.21 4.37 0.517 − 0.19 − 3.47 3.09 0.910 − 1.01 − 4.26 2.24 0.54 
Non-Bioaccessible 
(3.39+ vs 
≤3.38 ng/m3)                 
dom hand 1.21 − 2.31 4.72 0.498 0.66 − 2.04 3.36 0.629 − 0.06 − 2.68 2.57 0.966 − 0.22 − 2.83 2.39 0.869 
nondom hand 1.2 − 2.87 5.27 0.561 0.6 − 2.68 3.89 0.718 − 0.20 − 3.42 3.01 0.901 − 0.53 − 3.67 2.62 0.741 
Total (Bio + Non- 
Bio) (16.48+ vs 
≤16.47 ng/m3)                 
dom hand 1.13 − 2.38 4.65 0.525 0.48 − 2.22 3.19 0.724 − 0.67 − 3.34 2.00 0.621 − 0.99 − 3.66 1.69 0.466 
nondom hand 2.46 − 1.59 6.51 0.231 1.76 − 1.51 5.04 0.288 0.56 − 2.72 3.83 0.737 − 0.05 − 3.27 3.18 0.977 
Fine fraction 
(PM2.5)                 
Bioaccessible 
(17.06+ vs 
≤17.05 ng/m3)                 
dom hand 3.56 0.09 7.03 0.044 3.67 1.05 6.3 0.006 3.01 0.44 5.58 0.022 2.82 0.25 5.39 0.032 
nondom hand 3.64 − 0.38 7.67 0.075 3.75 0.53 6.97 0.023 3.00 − 0.17 6.17 0.064 2.58 − 0.54 5.7 0.104 
Non-Bioaccessible 
(5.81+ vs 
≤5.80 ng/m3)                 
dom hand 2.73 − 0.76 6.22 0.124 2.75 0.09 5.4 0.043 1.92 − 0.70 4.53 0.150 1.88 − 0.73 4.48 0.156 
nondom hand 1.56 − 2.5 5.62 0.449 1.58 − 1.69 4.85 0.341 0.60 − 2.64 3.83 0.716 0.51 − 2.64 3.67 0.749 
Total (Bio + Non- 
Bio) (25.01+ vs 
≤25.00 ng/m3)                 
dom hand 3.41 − 0.06 6.88 0.054 3.21 0.57 5.85 0.017 2.24 − 0.40 4.88 0.096 2.06 − 0.58 4.69 0.125 





m3)                 
dom hand 1.45 − 2.06 4.96 0.416 1.05 − 1.65 3.75 0.442 − 0.04 − 2.71 2.63 0.975 − 0.2 − 2.86 2.46 0.881 
nondom hand 2.48 − 1.58 6.53 0.229 2.07 − 1.2 5.34 0.212 0.90 − 2.36 4.17 0.585 0.59 − 2.6 3.79 0.714 
Biomarkers                 
Blood Mn 
(9.59+vs 
≤9.58μg/L)                 
dom hand − 5.33 − 8.73 − 1.94 0.002 − 3.17 − 5.87 − 0.46 0.022 − 2.68 − 5.30 − 0.06 0.045 − 2.63 − 5.23 − 0.03 0.048 
nondom hand − 5.24 − 9.2 − 1.27 0.01 − 2.94 − 6.26 0.38 0.082 − 2.39 − 5.62 0.85 0.147 − 2.3 − 5.45 0.86 0.153 
Scalp hair Mn 
(185.31+vs 
≤185.30 ng/g)                 
dom hand − 0.28 − 3.98 3.42 0.881 0.68 − 2.22 3.57 0.645 0.61 − 2.16 3.39 0.663 0.64 − 2.12 3.39 0.648 
nondom hand − 1.87 − 6.14 2.41 0.389 − 0.89 − 4.43 2.66 0.622 − 0.96 − 4.37 2.45 0.579 − 0.91 − 4.24 2.42 0.589 
Fingernails Mn 
(555.28+ vs ≤
555.28 ng/g)                 
dom hand 6.04 2.45 9.63 0.001 2.69 − 0.3 5.68 0.077 1.93 − 0.96 4.82 0.189 1.7 − 1.17 4.58 0.243 
nondom hand 7.24 3.04 11.44 0.001 3.67 − 0.01 7.36 0.051 2.84 − 0.76 6.44 0.121 2.37 − 1.13 5.87 0.182 
IES = Industrial Emission Source. dom = dominant. nondom = nondominant. MD = Mean Difference. MDa1 = MD adjusted for age and sex. MDa2 = MD adjusted for 
age, sex, and educational level. MDa3 = MD adjusted for age, sex, educational level, and years of residence. *A positive MD indicates worse motor function (higher time 
to complete the test) in exposed to higher Mn levels. 
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Table 4 
Mean Differences for Finger Tapping test (dominant and nondominant hand) according to Mn exposure indices and biomarkers.   
Finger Tapping Test (number of taps in 10 s)  
MD 
crude 
95 % CI p 
value 
MDa1 95 % CI p 
value 
MDa2 95 % CI p 
value 
MDa3 95 % CI p 
value 
Exposure indices                 
Source distance 
from IES (≤ 1.5 
vs 1.5þ km)                 
dom hand − 3.09 − 7.00 0.81 0.120 − 1.95 − 5.68 1.79 0.304 − 1.70 − 5.57 2.17 0.387 − 1.41 − 5.36 2.54 0.482 
nondom hand − 1.51 − 5.58 2.57 0.466 − 0.29 − 4.20 3.63 0.884 0.47 − 3.56 4.50 0.819 1.17 − 2.90 5.24 0.570 
PM personal 
samplers (ng/ 
m3)                 
Coarse fraction 
(PM10-2.5)                 
Bioaccessible 
(13.62+ vs 
≤13.61 ng/m3)                 
dom hand − 0.26 − 4.21 3.68 0.896 0.37 − 3.34 4.09 0.842 0.77 − 3.07 4.60 0.693 1.12 − 2.78 5.01 0.572 
nondom hand − 1.69 − 5.77 2.38 0.413 − 1.08 − 4.96 2.79 0.581 0.84 − 4.40 3.57 0.838 0.20 − 3.81 4.22 0.920 
Non-Bioaccessible 
(3.39+ vs ≤3.38 
ng/m3)                 
dom hand 0.45 − 3.50 4.39 0.823 0.84 − 2.87 4.54 0.656 1.08 − 2.67 4.84 0.570 1.22 − 2.55 4.98 0.524 
nondom hand 0.83 − 3.25 4.91 0.688 1.23 − 2.63 5.10 0.530 1.72 − 2.18 5.61 0.384 1.98 − 1.89 5.84 0.314 
Total (Bio + Non- 
Bio) (16.48+ vs 
≤16.47 ng/m3)                 
dom hand − 0.72 − 4.67 3.22 0.717 − 0.29 − 4.00 3.42 0.877 0.05 − 3.78 3.88 0.978 0.30 − 3.57 4.17 0.878 
nondom hand − 1.54 − 5.62 2.54 0.457 − 1.10 − 4.96 2.77 0.576 − 0.43 − 4.41 3.54 0.830 0.04 − 3.95 4.02 0.986 
Fine fraction 
(PM2.5)                 
Bioaccessible 
(17.06+ vs 
≤17.05 ng/m3)                 
dom hand − 0.79 − 4.73 3.16 0.694 − 0.45 − 4.16 3.25 0.809 − 0.23 − 3.99 3.53 0.903 − 0.05 − 3.84 3.73 0.978 
nondom hand − 2.99 − 7.04 1.07 0.147 − 2.71 − 6.55 1.14 0.166 − 2.31 − 6.19 1.58 0.242 − 1.98 − 5.86 1.90 0.314 
Non-Bioaccessible 
(5.81+ vs ≤5.80 
ng/m3)                 
dom hand 0.17 − 3.78 4.11 0.932 0.04 − 3.67 3.74 0.985 0.33 − 3.46 4.11 0.865 0.36 − 3.43 4.15 0.851 
nondom hand 0.89 − 3.19 4.97 0.666 0.77 − 3.09 4.64 0.693 1.39 − 2.53 5.31 0.485 1.45 − 2.44 5.34 0.461 
Total (Bio + Non- 
Bio) (25.01+ vs 
≤25.00 ng/m3)                 
dom hand − 0.29 − 4.24 3.65 0.884 − 0.07 − 3.77 3.63 0.969 0.29 − 3.54 4.11 0.883 0.44 − 3.40 4.29 0.819 
nondom hand − 2.12 − 6.19 1.95 0.304 − 1.91 − 5.76 1.94 0.328 − 1.30 − 5.26 2.66 0.517 − 1.01 − 4.96 2.95 0.615 
All fractions 
(PM10) (43.88+
vs ≤43.87 ng/ 
m3)                 
dom hand − 0.05 − 3.99 3.90 0.982 − 0.24 − 3.95 3.47 0.898 0.10 − 3.72 3.93 0.959 0.23 − 3.61 4.06 0.907 
nondom hand − 1.60 − 5.68 2.48 0.439 − 1.74 − 5.60 2.12 0.374 − 1.13 − 5.09 2.84 0.574 − 0.89 − 4.84 3.06 0.656 
Biomarkers                 
Blood Mn (9.59+ vs 
≤9.58μg/L)                 
dom hand 1.37 − 2.57 5.31 0.493 1.49 − 2.28 5.27 0.435 1.35 − 2.46 5.16 0.484 1.31 − 2.50 5.13 0.497 
nondom hand 2.52 − 1.54 6.58 0.221 2.47 − 1.46 6.40 0.216 2.17 − 1.77 6.11 0.278 2.10 − 1.82 6.01 0.291 
Scalp hair Mn 
(185.31+ vs 
≤185.30 ng/g)                 
dom hand 4.36 0.40 8.33 0.031 2.62 − 1.24 6.47 0.182 2.64 − 1.22 6.50 0.178 2.62 − 1.24 6.48 0.181 
nondom hand 3.57 − 0.57 7.71 0.091 1.75 − 2.24 5.74 0.386 1.79 − 2.17 5.76 0.372 1.75 − 2.17 5.67 0.378 
Fingernails Mn 
(555.28+ vs ≤
555.28 ng/g)                 
dom hand − 3.74 − 8.01 0.52 0.085 − 1.92 − 6.02 2.18 0.355 − 1.78 − 5.94 2.39 0.399 − 1.72 − 5.92 2.48 0.419 
nondom hand − 5.90 − 10.14 − 1.65 0.007 − 4.27 − 8.44 − 0.10 0.045 − 3.93 − 8.15 0.29 0.067 − 3.69 − 7.91 0.54 0.087 
IES = Industrial Emission Source. dom = dominant. nondom = nondominant. MD = Mean Difference. MDa1 = MD adjusted for age and sex. MDa2 = MD adjusted for 
age, sex, and educational level. MDa3 = MD adjusted for age, sex, educational level, and years of residence. *A negative MD indicates worse motor function (lower 
number of taps in 10 s) in exposed to higher Mn levels. 
L. Ruiz-Azcona et al.                                                                                                                                                                                                                           
Neurotoxicology 87 (2021) 195–207
203
Tables S11 and S12). 
In relation to biomarkers, a crude lower number of taps in the FTT 
were observed in participants with higher Mn fingernails levels: crude 
MD for the dom hand = -3.74 (3.74 lower taps); 95%CI (8.01 to 0.53), p 
= 0.085 and crude MD for the nondom hand = -5.90; 95%CI (-10.14 to 
-1.65), p = 0.007 (see Tables 4 and S10). After adjusting for the age, sex 
and educational level, these associations also diminished, losing statis-
tical significance: adjusted MD for the dom hand = -1.78; 95%CI (-5.94 
to 2.39), p = 0.399 and adjusted MD for the nondom = -3.93; 95%CI 
(-8.15 to 0.29), p = 0.067 (see Table 4). In the form of ORs, crude and 
adjusted higher associations were observed also for the nondom hand, 
but without yielding statistical significance: ORa2 nondom hand = 1.58; 
95%CI (0.70–3.57), p = 0.266 (see Tables S11 and S12). 
Regarding Dynamometer, the mean of the grip strength was 29.35 
and 26.91 kg (SD = 9.30 and 9.16), with medians of 27.70 y 24.70 kg for 
the dom and nondom hands respectively. The medians when stratified 
Table 5 
Mean Differences for Dynamometer test (dominant and nondominant hand) according to Mn exposure indices and biomarkers.   
Dynamometer (kg)        
MD 
crude 
95 % CI p 
value 
MDa1 95 % CI p 
value 
MDa2 095 CI p 
value 
MDa3 95 % CI p 
value 
Exposure indices                 
Source distance 
from IES (≤ 1.5 vs 
1.5þ km)                 
dom hand − 1.49 − 4.72 1.74 0.363 − 0.02 − 1.87 1.83 0.984 − 0.32 − 2.23 1.59 0.741 − 0.13 − 2.08 1.81 0.892 
nondom hand − 0.75 − 3.94 2.44 0.642 0.67 − 1.34 2.68 0.511 0.12 − 1.93 2.17 0.907 0.42 − 1.66 2.50 0.691 
PM personal 
samplers (ng/m3)                 
Coarse fraction 
(PM10-2.5)                 
Bioaccessible (13.62+ vs 
≤13.61 ng/m3)                 
dom hand − 0.06 − 3.30 3.19 0.973 0.98 − 0.85 2.80 0.291 0.75 − 1.13 2.64 0.429 0.96 − 0.95 2.87 0.322 
nondom hand 0.67 − 2.52 3.86 0.677 1.65 − 0.32 3.62 0.100 1.19 − 0.83 3.20 0.245 1.50 − 0.54 3.53 0.148 
Non-Bioaccessible 
(3.39+ vs ≤3.38 ng/ 
m3)                 
dom hand − 0.67 − 3.90 2.58 0.685 − 0.18 − 2.01 1.65 0.844 − 0.36 − 2.21 1.49 0.698 − 0.29 − 2.15 1.56 0.755 
nondom hand − 0.65 − 3.84 2.54 0.688 − 0.19 − 2.18 1.80 0.850 − 0.54 − 2.53 1.44 0.588 − 0.44 − 2.42 1.54 0.661 
Total (Bio + Non-Bio) 
(16.48+ vs ≤16.47 
ng/m3)                 
dom hand 0.52 − 2.72 3.76 0.750 1.05 − 0.78 2.87 0.258 0.83 − 1.05 2.71 0.384 0.98 − 0.91 2.88 0.307 
nondom hand 1.34 − 1.85 4.52 0.408 1.84 − 0.13 3.80 0.066 1.39 − 0.62 3.40 0.172 1.62 − 0.39 3.63 0.113 
Fine fraction (PM2.5)                 
Bioaccessible (17.06+ vs 
≤17.05 ng/m3)                 
dom hand 0.27 − 2.98 3.51 0.872 1.06 − 0.76 2.88 0.253 0.90 − 0.94 2.75 0.334 1.02 − 0.84 2.87 0.280 
nondom hand 0.35 − 2.84 3.55 0.827 1.09 − 0.89 3.07 0.277 0.76 − 1.22 2.74 0.448 0.92 − 1.06 2.90 0.360 
Non-Bioaccessible 
(5.81+ vs ≤5.80 ng/ 
m3)                 
dom hand − 0.77 − 4.01 2.47 0.639 − 1.05 − 2.87 0.77 0.255 − 1.32 − 3.17 0.53 0.160 − 1.30 − 3.15 0.55 0.166 
nondom hand 0.64 − 2.55 3.83 0.692 0.38 − 1.61 2.36 0.707 − 0.05 − 2.05 1.94 0.957 − 0.03 − 2.02 1.96 0.979 
Total (Bio + Non-Bio) 
(25.01+ vs ≤25.00 
ng/m3)                 
dom hand 0.91 − 2.33 4.14 0.581 1.26 − 0.56 3.07 0.173 1.05 − 0.82 2.92 0.268 1.15 − 0.73 3.03 0.229 
nondom hand 1.33 − 1.85 4.51 0.410 1.66 − 0.31 3.63 0.097 1.21 − 0.80 3.21 0.237 1.34 − 0.66 3.35 0.187 
All fractions (PM10) 
(43.88+ vs ≤43.87 
ng/m3)                 
dom hand 2.70 − 0.51 5.91 0.098 2.03 0.24 3.82 0.027 1.88 0.02 3.73 0.047 1.96 0.10 3.81 0.039 
nondom hand 3.37 0.24 6.51 0.035 2.75 0.83 4.68 0.005 2.37 0.40 4.35 0.019 2.49 0.52 4.46 0.014 
Biomarkers                 
Blood Mn (9.59+ vs 
≤9.58μg/L)                 
dom hand − 1.19 − 4.43 2.04 0.467 0.45 − 1.42 2.31 0.637 0.58 − 1.30 2.45 0.542 0.56 − 1.32 2.43 0.557 
nondom hand − 2.08 − 5.25 1.09 0.197 − 0.63 − 2.66 1.40 0.540 − 0.39 − 2.40 1.63 0.705 − 0.42 − 2.42 1.59 0.681 
Scalp hair Mn (185.31+
vs ≤185.30 ng/g)                 
dom hand 4.00 0.77 7.23 0.016 0.54 − 1.33 2.41 0.569 0.52 − 1.34 2.38 0.580 0.51 − 1.35 2.36 0.589 
nondom hand 3.42 0.23 6.62 0.036 0.22 − 1.89 2.32 0.839 0.19 − 1.89 2.26 0.858 0.17 − 1.89 2.24 0.870 
Fingernails Mn 
(555.28+ vs ≤
555.28 ng/g)                 
dom hand − 1.83 − 5.31 1.65 0.299 − 0.15 − 2.14 1.84 0.883 − 0.25 − 2.26 1.77 0.809 − 0.22 − 2.25 1.82 0.834 
nondom hand − 1.17 − 4.55 2.21 0.495 0.54 − 1.52 2.60 0.606 0.32 − 1.76 2.39 0.763 0.39 − 1.70 2.48 0.712 
IES = Industrial Emission Source. dom = dominant. nondom = nondominant. MD = Mean Difference. MDa1 = MD adjusted for age and sex. MDa2 = MD adjusted for 
age, sex, and educational level. MDa3 = MD adjusted for age, sex, educational level, and years of residence*A negative MD indicates worse motor function (lower grip 
strength) in exposed to higher Mn levels. 
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by sex were 40.10 kg for the dom hand in males and 24.80 kg in females; 
and 38.80 kg for the nondom hand in males and 23.30 kg in females (see 
Table S5). 
Mixed crude MDs were obtained (from the 22 crude test, 10 were 
negative indicating a worse grip strength in exposed, and 12 were pos-
itive. After adjusting for age, sex and educational level, the positive MDs 
remained positive (two of them yielding statistical significance). None of 
the adjusted negative MDs reached statistical significance (see Tables 5 
and S13). When Dynamometer results were dichotomous categorized 
into high vs low values with different cut-off points for women and men, 
all OR were not statistically significant, but most of them were <1 
against the hypothesis of a worse grip strength among exposed (see 
Tables S14 and S15). 
For Mn-Blood levels, lower times to complete the test were observed 
(contrary to our hypothesis) in relation to GP (especially for dom hand 
with significant adjusted MD results) (see Table 3). Nonsignificant lower 
times were obtained in relation to FTT in both dom and nondom hands 
(contrary also to our hypothesis) (see Table 4). Regarding Dynamom-
eter, mixed results were obtained (see Table 5). For scalp hair, mixed 
results were obtained for GP whereas nonsignificant results contrary to 
our hypothesis were obtained for FTT and Dynamometer, supported by 
correlation results (See Tables 3–5 and S7). 
4. Discussion 
Each of our motor test analyzed evaluates a different domain. GP test 
evaluates “eye-hand coordination and motor speed”, FTT evaluates 
“self-directed manual speed” and Dynamometer evaluates “grip 
strength” (Ruiz-Azcona et al., 2021; Strauss et al., 2006). 
Among the three motor tests analyzed, our study supports poorer 
motor function, especially as assessed by GP test, particularly in terms of 
“proximity to IES”, “bioaccessible-fine fraction as determined by PEMs”, 
and “Mn fingernails levels”. However, our findings were clearly affected 
by confounding, and only the adjusted MD for Mn bioaccessible-fine 
fraction remained of sufficient magnitude to maintain statistical signif-
icance. The rest associations diminished, and although they remained 
indicating a worse motor function, they lost statistical significance. It 
possibly denotes that the statistical power of our study to detect small 
adjusted differences was not high enough with our final sample size of 
130 participants, suggesting that, statistical power was not enough to 
achieve a low standard error to rule out the role of chance in our results. 
In any case, our results support the GP results of the studies published by 
Bowler et al. (2012) and Viana et al. (2014), allowing to obtain a more 
precise estimation of the effect size in further meta-analyses. 
Regarding FTT, associations in relation to proximity to IES, PEMs 
determinations and fingernails were also affected by confounding, but 
would support also the Bowler et al. (2012) and Lucchini et al. (2014) 
results of this test indicating a worse motor function. 
To the best of our knowledge, results on Mn exposure and “hand 
strength” as determined by Dynamometer have only been published in 
one study (Bowler et al., 2012) without observing an association. As 
expected, large differences have been found in our study according to 
sex. After adjusting for it, most of our MDs association were negative 
(supporting a negative association) but without reaching statistical 
significance. When results were dichotomous categorized into high vs 
low values, most of ORs were <1 against the hypothesis of a worse grip 
strength, so very inconclusive and mixed results were obtained. 
In relation to “years of residence” as a confounding variable, on the 
one hand, the variable years of residence was associated in our study 
with motor function, meeting the first criterion to consider a variable as 
a confounding variable (Rothman, 1986). On the other hand, this vari-
able can be interpreted as part of the exposure itself instead as a con-
founding variable, with exposure being understood as a composite 
resulting from the product of intensity and duration. In addition, a 
correlation between age and years residing could exist. Therefore, two 
multivariate models were performed, the first one with all predefined 
covariates but excluding this variable and the second one including it. As 
expected, the latter multivariate model provided the lowest MD and OR 
values, reflecting the adjusted effect of exposure intensity by itself, with 
independence of years of exposure. Apart from confounding, the pres-
ence of other potential biases have been trying to be minimized by the 
use of the same schedules and procedures in all participants, including 
the order of test by a single trained investigator under the same condi-
tions, to avoid any differential misclassification. Lastly, as this is an 
exploratory study, another limitation relates to the high number of 
comparisons made in our study; and thus, we cannot rule out that some 
of the associations were spurious or due to chance (i.e., false-positive 
associations) by a multiple-test concern specially as refers to our mul-
tiple coarse & fine and bioaccessible & non-bioaccessible fractions re-
sults. Nevertheless, the concordance and homogeneity between results 
among the different analytical strategies in the form of Spearman cor-
relations, MDs and ORs would support the internal validity of results. 
Our study, as the rest of published studies on the relationship be-
tween environmental Mn airborne exposure in adults and motor func-
tion, has a cross-sectional design, with the limitations inherent to this 
design including the lack of longitudinal data on both the Mn exposure 
and the motor function determinations. With regards to exposure, most 
of our participants met both residency criteria suggesting a continuous 
and stable long-term exposure that covering also the potential latency 
period between exposure and the onset of effects on motor function. In 
any case, further follow-up studies are clearly needed to deep in the 
motor function effects derived from the environmental airborne Mn 
exposure. The clinical relevance of possible poorer motor function re-
sults of small magnitude in addition to the influence of aging must also 
be elucidated in order to obtain scientific evidence of the long term 
public health Mn exposure consequences for all ages. 
While there are no longitudinal studies in the specific Mn environ-
mental field in adults in relation to motor function, some cohort studies 
have been conducted in the occupational field. Mn alloy workers were 
examined in a follow-up study 14 years after exposure ceased 
(1990–2004 at a Canadian facility), having poorer scores compared to 
referents both in the initial and follow-up examinations for several 
motor tasks of the Luria Motor Scale (Bouchard et al., 2007). After 3.5 
years of cessation of confined space welding, Bowler et al. (2011) re-
ported that motor dexterity/tactile function and graphomotor tremor 
improved significantly, while psychomotor speed remained unchanged. 
Unified Parkinson Disease Rating Scale motor subsection (UPDRS) re-
sults did not change compared to baseline, whereas rigidity, dominant 
postural hand tremor and body sway worsened. Racette et al. (2017) 
study supported a Mn dose-dependent progression of parkinsonism in 
Mn exposed welders as assessed by the UPDRS part 3. In contrast, a 
nationwide record linkage study in Sweden did not offer support for a 
relation between being employment as a welder and Parkinson’s disease 
or any other specific basal ganglia and movement disorders (Fored et al., 
2006). Evidence of association was not found either in a large Danish 
cohort study (Kenborg et al., 2012). In Washington, US, 56 asymptom-
atic welder trainees exposed to low levels of Mn with no previous 
occupational Mn exposure were observed over the course of a 
five-quarter traineeship. When adjusting for possible learning effects, 
there were no associations between cumulative exposure and UPDRS 
part 3 score or Grooved Pegboard time. Interestingly, in a subset of 17 
welders in which T1-weighted magnetic resonance images were per-
formed, the basal ganglia exhibited statistically significant increases in 
signal intensity in relation to increased cumulative Mn exposure, sug-
gesting that T1-weighted changes can be detected in the brain even at 
very low levels of exposure among humans before any clinically evident 
deficits, suggesting the possible identification of a T1 threshold of 
toxicity at which clinical symptoms begin to manifest in a continued 
follow-up (Baker et al., 2015). Lastly, an exploratory cohort study from 
southern Sweden, evaluated associations between welding and expres-
sion of 87 putative neurology-related proteins in serum, identifying five 
of them that were differentially expressed (Gliga et al., 2020). An 
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increasing number of longitudinal studies is also available evaluating 
Mn exposure during pregnancy, childhood and at youth ages and its 
adverse effects at different ages including motor function. Adverse 
motor function associations have been reported in Italian adolescents 
11–14 years old (Lucchini et al., 2012), and at 2 years of age in relation 
to in utero exposure (Lin et al., 2013), but no associations have been 
reported in others (Gunier et al., 2015; Claus Henn et al., 2017; 
Andiarena et al., 2017; Soler-Blasco et al., 2020). 
In a general context, the potential health effects from the metal(loid) 
s present in PM depend upon the solubility of elements in the human 
body. This solubility is influenced by the chemical speciation of these 
metal(loid)s and by the size and shape of particles (Kelly and Fussell, 
2012), but also by the chemical composition of the leaching fluid (i.e., 
the biological fluid where PM will be partially dissolved). In this context, 
bioaccessibility is defined as the fraction of the total metal(loid) con-
centration released from an environmental matrix into a synthetic bio-
logical fluid and becomes available for absorption (Manjón et al., 2020). 
Whereas conventional studies only consider the total concentration of 
some trace metals in PM, the bioaccessible concentration of PM-bound 
trace metal(loid)s instead of total content may better represent the 
exposure risk of such pollutants in humans (Hernández-Pellón et al., 
2018; Weggeberg et al., 2019). Our results in GP and FTT for the fine 
bioaccessible fraction would be supported by this rational. Nevertheless, 
no great differences were found when comparing bio versus 
non-bioaccessible in the coarse fraction, supporting the hypothesis that 
the fine mode can induce worse motor function than the coarse one. 
Human biomonitoring, is defined as the measurement or estimation 
of human exposure to environmental contaminants by determining the 
concentration of contaminants and/or their metabolites or other bio-
logical parameters in biological samples (blood, hair, nails, etc.) 
(Democophes, 2012). The usefulness of a biomarker should be evaluated 
by its ability to predict health effects; it should also be able to anticipate 
any deterioration as a result of short- or long-term exposure (Viana et al., 
2014; Zheng et al., 2011). Currently there is no consensus on which 
biomarker better defines the dose-effect relationship for the specific case 
of Mn exposure (Fernández-Olmo et al., 2020). 
Blood aims to estimate short term exposure (Aschner et al., 2007; 
Michalke and Fernsebner, 2014; Ntihabose et al., 2018). The hair 
growth rate of approximately 1 cm per month provides an exposure 
estimate of 1–6 months (Haynes et al., 2015) whereas the slower growth 
rate of nails allows to estimate low-level chronic exposure (Viana et al., 
2014). Some authors state that blood is not a good biomarker of Mn 
exposure because the average time it remains in blood is much shorter 
than in tissues and intracellular compartments (Zheng et al., 2011). This 
seems to be particularly true when Mn is inhaled, so in occupational 
context, although higher levels of Mn in blood of individuals exposed to 
high concentrations of Mn in workplaces are found, it is difficult to 
quantify how the pulmonary uptake of Mn-bearing particles contributes 
to the overall increase of Mn in blood (Roth, 2006). Our results contrary 
to our hypothesis for Blood Mn, and our positive correlation between 
source distance from the IES and Blood Mn levels (contrary also to our 
hypothesis) should be considered in this context (estimation of 
short-term environmental exposure in one hand and no specific appro-
priateness for inhaled Mn exposure in the other hand). In addition, Mn is 
an essential micronutrient so its concentration is metabolically regu-
lated in the blood supply. In this regard, other authors consider that hair 
and nails are better Mn specific biomarkers for epidemiological purposes 
because of their long-term exposure, although the mechanisms of Mn 
uptake in hair are not well known either (Bouchard et al., 2011; Coetzee 
et al., 2016; Haynes et al., 2015; Viana et al., 2014). Our homogeneous 
results for fingernails in relation to motor functions test results and our 
negative significant correlation with source distance from the IES, sup-
port the consideration of nails as a promising biomarker, in agreement 
with the recent literature for both fingernails (Butler et al., 2019; Lucas 
et al., 2015; Viana et al., 2014) and toenails (Ntihabose et al., 2018; Reis 
et al., 2015; Rodrigues et al., 2018a, b). 
Lastly, our study shows variability with relatively high SDs of Mn 
concentrations in all the studied fractions; such variations in airborne 
Mn concentrations measured in the personal samplers are likely due to 
differences in emissions, weather, including seasonal changes, and the 
amount of time people spent outdoors. In spite of this variability, a 
correlation in adults between source distance from the IES and Mn 
airborne levels was observed, also maintained when differentiating be-
tween coarse & fine and bioaccessible & non-bioaccessible fractions, 
reflecting that source distance from the IES is a valid surrogate of overall 
Mn airborne exposure, and contextualizing our study population as 
exposed to high levels of airborne Mn when comparing with reference 
guideline given by WHO (150 ng/m3) and the Reference Concentration 
(RfC) given by US EPA (50 ng/m3) (annual basis). They are also 
contextualized as highly exposed when compared to published studies as 
ours, which have been conducted in areas near Mn ferroalloys plants: In 
Valcamonica (Italy), means of 26.4 ng/m3 using PM10 PEMs have been 
reported (Lucchini et al., 2014) and mean modelled Mn values of 180 
ng/m3 in PM10 and 50 ng/m3 in PM2.5, were reported in Marietta (US) 
(Bowler et al., 2012, 2016; Kim et al., 2011). Lastly, a mean of 151 
ng/m3 in PM2.5 has been reported in Simões Filho (Brazil) (Mene-
zes-Filho et al., 2009), which is the same area studied by Viana et al. 
(Viana et al., 2014), where a Mn ferroalloys plant is located. 
As a conclusion, our statistically significant adjusted results for the 
Mn bioaccessible-fine fraction and the GP test results, together with the 
available evidence, support an association between chronic Mn expo-
sure and effects on motor function, and the need to regulate the airborne 
Mn levels. 
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